Literature DB >> 22452790

Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.

N Dekker1, J Meijer, M Koeter, W van den Brink, N van Beveren, R S Kahn, D H Linszen, J van Os, D Wiersma, R Bruggeman, W Cahn, L de Haan, L Krabbendam, I Myin-Germeys.   

Abstract

BACKGROUND: Cannabis use is associated with an earlier age at onset of psychotic illness. The aim of the present study was to examine whether this association is confounded by gender or other substance use in a large cohort of patients with a non-affective psychotic disorder.
METHOD: In 785 patients with a non-affective psychotic disorder, regression analysis was used to investigate the independent effects of gender, cannabis use and other drug use on age at onset of first psychosis.
RESULTS: Age at onset was 1.8 years earlier in cannabis users compared to non-users, controlling for gender and other possible confounders. Use of other drugs did not have an additional effect on age at onset when cannabis use was taken into account. In 63.5% of cannabis-using patients, age at most intense cannabis use preceded the age at onset of first psychosis. In males, the mean age at onset was 1.3 years lower than in females, controlling for cannabis use and other confounders.
CONCLUSIONS: Cannabis use and gender are independently associated with an earlier onset of psychotic illness. Our findings also suggest that cannabis use may precipitate psychosis. More research is needed to clarify the neurobiological factors that make people vulnerable to this precipitating effect of cannabis.

Entities:  

Mesh:

Year:  2012        PMID: 22452790     DOI: 10.1017/S0033291712000062

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

1.  Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.

Authors:  Laura Koenders; Marise W J Machielsen; F J van der Meer; Angelique C M van Gasselt; Carin J Meijer; Wim van den Brink; Maarten W J Koeter; Matthan W A Caan; Janna Cousijn; Anouk den Braber; Dennis van 't Ent; Maaike M Rive; Aart H Schene; Elsmarieke van de Giessen; Chaim Huyser; Bart P de Kwaasteniet; Dick J Veltman; Lieuwe de Haan
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

2.  Mechanisms Underlying Sex Differences in Cannabis Use.

Authors:  Katina C Calakos; Shivani Bhatt; Dawn W Foster; Kelly P Cosgrove
Journal:  Curr Addict Rep       Date:  2017-10-19

3.  Clozapine Treatment and Cannabis Use in Adolescents with Psychotic Disorders - A Retrospective Cohort Chart Review.

Authors:  Sephora M Tang; Aylar Ansarian; Darren B Courtney
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2017-03-01

4.  Cannabis use and risk of schizophrenia: a Mendelian randomization study.

Authors:  J Vaucher; B J Keating; A M Lasserre; W Gan; D M Lyall; J Ward; D J Smith; J P Pell; N Sattar; G Paré; M V Holmes
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

5.  Familial and socioeconomic contributions to premorbid functioning in psychosis: Impact on age at onset and treatment response.

Authors:  Alex Hatzimanolis; Pentagiotissa Stefanatou; Emmanouil Kattoulas; Irene Ralli; Stefanos Dimitrakopoulos; Stefania Foteli; Ioannis Kosteletos; Leonidas Mantonakis; Mirjana Selakovic; Rigas-Filippos Soldatos; Ilias Vlachos; Lida-Alkisti Xenaki; Nikolaos Smyrnis; Nicholas C Stefanis
Journal:  Eur Psychiatry       Date:  2020-04-29       Impact factor: 5.361

6.  Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis.

Authors:  Priyanthi B Gjerde; Synne W Steen; Trude S J Vedal; Nils Eiel Steen; Elina J Reponen; Ole A Andreassen; Vidar M Steen; Ingrid Melle
Journal:  Front Psychiatry       Date:  2022-03-29       Impact factor: 4.157

7.  Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

Authors:  Marta Di Forti; Hannah Sallis; Fabio Allegri; Antonella Trotta; Laura Ferraro; Simona A Stilo; Arianna Marconi; Caterina La Cascia; Tiago Reis Marques; Carmine Pariante; Paola Dazzan; Valeria Mondelli; Alessandra Paparelli; Anna Kolliakou; Diana Prata; Fiona Gaughran; Anthony S David; Craig Morgan; Daniel Stahl; Mizanur Khondoker; James H MacCabe; Robin M Murray
Journal:  Schizophr Bull       Date:  2013-12-17       Impact factor: 9.306

8.  Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.

Authors:  Christina J Hsieh; Douglass Godwin; Daniel Mamah
Journal:  Front Psychiatry       Date:  2016-08-26       Impact factor: 4.157

Review 9.  Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review.

Authors:  Laura Prieto-Arenas; Ignacio Díaz; M Carmen Arenas
Journal:  Brain Sci       Date:  2022-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.